Tiefenbacher Group celebrating a Decade of Excellence:
Tiefenbacher Group is delighted to announce a significant milestone in the journey of Delorbis Pharmaceuticals Ltd, our state-of-the-art manufacturing site and branded business on the beautiful island of Cyprus. This year, Delorbis celebrates its 10th anniversary, marking a decade of European excellence and meaningful contributions to the pharmaceutical industry.
On this special occasion, Delorbis hosted a celebratory event at their premises. Equally inviting not only dedicated employees but also close partners who have been a great support and an integral part of the success throughout the years. The day was filled with joy, accompanied by lively music, a vibrant cocktail bar, delicious food and of course, no birthday is complete without a magnificent birthday cake!
Delorbis turns 10
As we look back on these 10 years, we are proud of what Delorbis has achieved. From the humble beginnings to becoming a recognized name in the industry, Delorbis continues to uphold the highest standards in pharmaceutical manufacturing. We look forward to continuing our shared commitment to innovation, quality and pioneering healthcare to improve the lives of patients around the world.
Here’s to the next 10 years of groundbreaking advancements, partnerships, and continued success!
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
